Medical News -- Medical Cost Containment Solution News -- Medical growth company offers software to enhance MRI accuracy and efficiency

Medical stock news -- Medical growth stock offers medical cost containment solution. Accuracy and efficiency of Magnetic Resonance Imaging, MRI, enhanced. New noninvasive blood flow analysis applications are under development. A new executive management team has been installed to accelerate sales and growth. This unique situation creates a potentially strong high return stock investment opportunity offered by this new medical growth company.

(PRWEB) September 23, 2003 -- Medical growth stock news -- A new executive management team has been installed to lead the growth and direction of NanoSignal Corporation (Stock Symbol = NNOS).

Information on the new team can be found at http://www.medical-msgl.us/medical-news.htm

This year the company introduced SLICES - a state-of-the-art Magnetic Resonance Imaging data processing tool that provides significant advantages and cost savings.

SLICES software allows the Radiologist and MRI Technologist to perform advanced imaging features beyond the capabilities of the standard MRI computer. For complete details on the medical cost containment solution and benefits offered by this new technology visit http://www.medical-msgl.us/magnetic-resonance.htm

NanoSignal Corporation has also acquired a company with innovative x-ray bar coding products (http://www.medical-msgl.us/x-ray-news.htm). This complimentary add-on product is expected to increase revenues.

The capabilities of SLICES are currently being expanding to provide noninvasive, turbulent blood flow analysis applications. See http://www.medical-msgl.us/blood-flow.htm

These advances would provide a new way to perform early analysis of vascular stricture and disease detection using current MRI machines. Scans for this technology could surpass the total number of MRI scans now being performed around the world.

For more information visit the links above or go directly to the companys web site at http://www.nanosignalcorp.com/main.htm

Note: Certain statements in this news release may contain "forward looking" information within the meaning of rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Act of 1934 and are subject to the safe harbor created by those rules. This release is for information purposes only. NanoSignal Corporation has neither approved nor disapproved this release. This release is not an offer or solicitation to buy securities. This information should not be considered to be any type of investment opinion or advice. All statements, other than statements of fact, included in this release, may include forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will be accurate and actual results and future events could differ materially from those anticipated in such statements.
###